Страница 1 од 19 резултати
BACKGROUND OF THE INVENTION
The present invention relates to a process for determining tumor-associated glycolinkage (hereunder referred to as TAG) in the body fluid of mammals, more particularly, TAG including glycoproteins, glycopeptides, glycolipids and/or sugars having a certain specific
BACKGROUND OF THE INVENTION
1. Technical Field
The present invention relates to a method of detecting pancreatic cancer, and more particularly to a method of detecting pancreatic cancer in which pathological haptoglobin is used as a tumor marker.
2. Background Art
Since pancreas is located deep in
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates to bifunctional glycoproteins having targeting protein and enzyme properties. More particularly, the invention relates to such proteins whose complements of carbohydrate residues have been modified in a manner that enhances
BACKGROUND OF THE INVENTION
This invention relates to a process for the determination of the malignant potential of a tumor, and diagnostic kits for carrying out the process. The process is suitable for the sensitive and specific determination of the malignant potential of a tumor.
Neoplastic
TECHNICAL FIELD OF THE INVENTION
This invention relates to the field of cancer vaccines. In particular, the application relates to carbohydrate-based immunogenic compositions containing fucose-enriched polysaccharides isolated from a fucose-containing extract of Ganoderma lucidum. More particularly,
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to a class of proteoglycans having fucosylated acidic glycan side chains bound to a protein backbone which have been found to stimulate selectively proliferation of natural killer (NK) cells and/or .gamma..delta.T cells.
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
Not Applicable
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to a class of proteoglycans having fucosylated acidic glycan side chains bound to a protein backbone which have been found to stimulate
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
Not Applicable
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to a class of proteoglycans having fucosylated acidic glycan side chains bound to a protein backbone which have been found to stimulate
FIELD OF THE INVENTION
The present invention relates generally to sulfone phosphonate compounds and their use in organic synthesis and, more particularly, to disulfone bis-phosphonates and their preparation and use as reagents in the synthesis of biologically relevant disulfones.
BACKGROUND OF THE
FIELD OF THE INVENTION
This invention relates generally to medicinal chemistry, and preferably to methods of synthesizing and identifying medically useful glyco-amino acids or glycopeptides which are characterized by their capacity to bind to one or more selectins CE-, L-, and
This invention relates to a monoclonal antibody and a method for the production thereof. More particularly, it relates to a monoclonal antibody specific for a .alpha..sub.1 -acid glycoprotein or specific for at least one antigenic determinant included in a sugar chain of the following formula which
CROSS REFERENCE TO RELATED APPLICATIONS
This application is the U.S. National Phase Application of PCT/HR2014/000022, filed Jun. 11, 2014, which claims priority to Croatian Patent Application No. P20130568A, filed Jun. 20, 2013, the contents of such applications being incorporated by reference
BACKGROUND OF THE INVENTION
Aging on the cellular level involves many paradoxes. On the one hand, many biochemical changes have been documented that suggest a variety of mechanisms of cellular aging. On the other hand, the simple expedient of increasing the expression of the enzyme telomerase is
FIELD OF THE INVENTION
The present invention relates to an anti-CD19 antibody having a variant Fc region having some specific amino acid modifications relative to a wild-type Fc region which confer one or several useful effector functions. The present invention relates in particular to chimeric,
FIELD OF THE INVENTION
The present invention relates to an anti-CD19 antibody having a variant Fc region having some specific amino acid modifications relative to a wild-type Fc region which confer one or several useful effector functions. The present invention relates in particular to chimeric,